We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Schering Sues Barr Over Brain Tumor Drug

Law360 (July 24, 2007, 12:00 AM EDT) -- Pharmaceutical company Schering Corp. filed suit against generic maker Barr Pharmaceuticals Inc. on Friday, alleging infringement of a patent covering Schering’s brain tumor treatment, Temodar.

Schering filed the complaint in the U.S. District Court for the District of Delaware along with patent holder Cancer Research Technology Ltd., a British research company that licensed the use of its patent exclusively to Schering. The companies claim that Barr and its subsidiary Barr Laboratories Inc. have infringed on their patent in their Abbreviated New Drug Application, filed with the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.